Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glycine receptor alpha 2 subunit (GLRA2) is a protein that forms part of the glycine receptor, a neurotransmitter-gated ion channel that mediates fast inhibitory synaptic transmission in the central nervous system, particularly during early development. Activation increases chloride conductance leading to hyperpolarization—thus inhibiting neuronal firing. Mutations or dysfunctions involving GLRA genes can result in neurological disorders such as startle disease/hyperekplexia. Disruption specifically affecting GlyRα₂ impairs cortical interneuron migration—a process implicated by some studies as relevant to neurodevelopmental disorders including autism spectrum disorder.
Activation increases chloride conductance leading to hyperpolarization, thus inhibiting neuronal firing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine receptor alpha 2 subunit (None).